Equities

Tempus AI Inc

TEM:NSQ

Tempus AI Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)52.48
  • Today's Change-5.67 / -9.75%
  • Shares traded9.07k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments198303278
Total Receivables, Net948982
Total Inventory292223
Prepaid expenses171917
Other current assets, total125.283.86
Total current assets350439404
Property, plant & equipment, net826835
Goodwill, net735316
Intangibles, net223737
Long term investments8.978.836.85
Note receivable - long term------
Other long term assets262531
Total assets564631531
LIABILITIES
Accounts payable544634
Accrued expenses1057555
Notes payable/short-term debt000
Current portion long-term debt/capital leases00.290.42
Other current liabilities, total735226
Total current liabilities233174115
Total long term debt450390239
Total debt450390239
Deferred income tax------
Minority interest------
Other liabilities, total15817087
Total liabilities841734441
SHAREHOLDERS EQUITY
Common stock0.010.010.01
Additional paid-in capital189.250
Retained earnings (accumulated deficit)(1397)(1138)(807)
Treasury stock - common(3.6)00
Unrealized gain (loss)------
Other equity, total0.010.02(0.01)
Total equity(277)(103)91
Total liabilities & shareholders' equity564631531
Total common shares outstanding165165165
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.